BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2019 11:18:56 AM | Browse: 833 | Download: 1371
 |
Received |
|
2019-10-30 16:43 |
|
Peer-Review Started |
|
2019-10-30 16:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-11-09 16:29 |
|
Revised |
|
2019-12-01 06:43 |
|
Second Decision |
|
2019-12-06 06:30 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-12-06 22:15 |
|
Articles in Press |
|
2019-12-06 22:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-12-10 01:47 |
|
Typeset the Manuscript |
|
2019-12-13 06:22 |
|
Publish the Manuscript Online |
|
2019-12-14 11:18 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Two-week bismuth-containing quadruple and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-labeled randomized trial
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
So Jeong Kim, Jun-Won Chung, Hyun Sun Woo, Su Young Kim, Jung Ho Kim, Yoon Jae Kim, Kyoung Oh Kim, Kwang An Kwon and Dong Kyun Park |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun-Won Chung, MD, PhD, Associate Professor, Division of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, 21, Namdong-daero 774 beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@daum.net |
| Key Words |
Helicobacter pylori; Therapy; Bismuth-containing quadruple therapy; Concomitant therapy; ; |
| Core Tip |
Both bismuth-containing quadruple therapy and concomitant therapy proved to be useful empirical first-line treatment options for Helicobacter pylori eradication in an area exhibiting high-level clarithromycin-resistance (> 15%). |
| Publish Date |
2019-12-14 11:18 |
| Citation |
Kim SJ, Chung JW, Woo HS, Kim SY, Kim JH, Kim YJ, Kim KO, Kwon KA, Park DK. Two-week bismuth-containing quadruple and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-labeled randomized trial. World J Gastroenterol 2019; 25(46): 6790-6798 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i46/6790.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i46.6790 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
